These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37936726)

  • 21. The efficacy of intravenous tranexamic acid administration at induction in definitive hip fracture surgery: Is there a role?
    Kanthasamy S; Guhan B; Chakravarty D; Parker MJ
    Injury; 2021 Aug; 52(8):2361-2366. PubMed ID: 33568279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures.
    Baruah RK; Borah PJ; Haque R
    J Orthop Surg (Hong Kong); 2016 Dec; 24(3):379-382. PubMed ID: 28031511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
    Costain D; Elder G; Fraser B; Slagel B; Kelly A; Cheong Y; Fera L
    Can J Surg; 2021 Aug; 64(4):E449-E456. PubMed ID: 34388107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial.
    Chen F; Jiang Z; Li M; Zhu X
    Hong Kong Med J; 2019 Apr; 25(2):120-126. PubMed ID: 30919809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial.
    Lasocki S; Capdevila X; Vielle B; Bijok B; Lahlou-Casulli M; Collange V; Grillot N; Danguy des Deserts M; Duchalais A; Delannoy B; Drugeon B; Bouzat P; David JS; Rony L; Loupec T; Léger M; Rineau E; ;
    Lancet Haematol; 2023 Sep; 10(9):e747-e755. PubMed ID: 37524101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of tranexamic acid in reducing allogeneic blood products in adolescent idiopathic scoliosis surgery.
    Sui WY; Ye F; Yang JL
    BMC Musculoskelet Disord; 2016 Apr; 17():187. PubMed ID: 27117696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trial.
    Cvetanovich GL; Fillingham YA; O'Brien M; Forsythe B; Cole BJ; Verma NN; Romeo AA; Nicholson GP
    JSES Open Access; 2018 Mar; 2(1):23-27. PubMed ID: 30675563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral Is as Effective as Intravenous Tranexamic Acid at Reducing Blood Loss in Thoracolumbar Spinal Fusions: A Prospective Randomized Trial.
    Yu CC; Fidai M; Washington T; Bartol S; Graziano G
    Spine (Phila Pa 1976); 2022 Jan; 47(2):91-98. PubMed ID: 34224510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of tranexamic acid on perioperative blood loss in transurethral resection of the prostate: A double-blind, randomized controlled trial.
    Vanderbruggen W; Brits T; Tilborghs S; Derickx K; De Wachter S
    Prostate; 2023 Dec; 83(16):1584-1590. PubMed ID: 37602525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of tranexamic acid for patients with intertrochanteric fractures treated with intramedullary fixation: A systematic review and meta-analysis of current evidence in randomized controlled trials.
    Jiang J; Xing F; Zhe M; Luo R; Xu J; Duan X; Xiang Z
    Front Pharmacol; 2022; 13():945971. PubMed ID: 36199695
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial.
    Oremus K; Sostaric S; Trkulja V; Haspl M
    Transfusion; 2014 Jan; 54(1):31-41. PubMed ID: 23614539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral versus intravenous tranexamic acid in elderly patients with intertrochanteric fracture undergoing proximal femur intramedullary nailing: A prospective cohort study.
    Li RY; Xie T; Zhao YK; Qi YM; Li YJ; Wang Z; Qiu XD; Sun J; Zhang M; Wang L; Chen H; Rui YF
    J Orthop Translat; 2022 May; 34():85-90. PubMed ID: 35847604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranexamic Acid Administration in Primary Total Hip Arthroplasty: A Randomized Controlled Trial of Intravenous Combined with Topical Versus Single-Dose Intravenous Administration.
    Yi Z; Bin S; Jing Y; Zongke Z; Pengde K; Fuxing P
    J Bone Joint Surg Am; 2016 Jun; 98(12):983-91. PubMed ID: 27307358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study protocol: haemostatic efficacy and safety of preemptive antifibrinolysis with multidose intravenous tranexamic acid in elderly hip fracture patients: design of a prospective randomised controlled trial.
    Liu J; Lei Y; Liao J; Liang X; Hu N; Huang W
    BMJ Open; 2021 Dec; 11(12):e047382. PubMed ID: 34907040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients.
    Gausden EB; Garner MR; Warner SJ; Levack A; Nellestein AM; Tedore T; Flores E; Lorich DG
    BMJ Open; 2016 Jun; 6(6):e010676. PubMed ID: 27329438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
    Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
    Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Optimal Dosing Regimen for Tranexamic Acid in Revision Total Hip Arthroplasty: A Multicenter Randomized Clinical Trial.
    Sershon RA; Fillingham YA; Abdel MP; Malkani AL; Schwarzkopf R; Padgett DE; Vail TP; Nam D; Nahhas C; Culvern C; Della Valle CJ;
    J Bone Joint Surg Am; 2020 Nov; 102(21):1883-1890. PubMed ID: 33148955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tranexamic Acid Administration at Hospital Admission Decreases Transfusion Rates in Geriatric Hip Fracture Patients Undergoing Surgery.
    Moran J; Kahan JB; Morris J; Joo PY; O'Connor MI
    Geriatr Orthop Surg Rehabil; 2022; 13():21514593221124414. PubMed ID: 36081840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty.
    Clavé A; Gérard R; Lacroix J; Baynat C; Danguy des Déserts M; Gatineau F; Mottier D
    Bone Joint J; 2019 Feb; 101-B(2):207-212. PubMed ID: 30700116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis.
    Baskaran D; Rahman S; Salmasi Y; Froghi S; Berber O; George M
    Hip Int; 2018 Jan; 28(1):3-10. PubMed ID: 28983887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.